Bank of Montreal
ARQT icon

Bank of Montreal’s Arcutis Biotherapeutics ARQT Stock Holding History

Bank of Montreal’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-677
Closed -$19K – 3715
2021
Q1 		$19K Sell
677
-2,539
-79% -$79.3K ﹤0.01% 4077
2020
Q4 		$89K Buy
3,216
+2,379
+284% +$58.3K ﹤0.01% 3646
2020
Q3 		$20K Buy
837
+83
+11% +$2.22K ﹤0.01% 3831
2020
Q2 		$22K Buy
+754
New +$21.8K ﹤0.01% 3802

Other funds holding ARQT

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Bank of Montreal's ARQT Position: Q2 2021 in Review

Bank of Montreal sold out of Arcutis Biotherapeutics (ARQT) in Q2 2021, closing a stake of 677 shares — an estimated $19K sold.

Bank of Montreal first reported a position in ARQT in Q2 2020 and held it in 4 quarters. The position peaked at $89K in Q4 2020. 102 funds tracked by Wall St. Rank hold ARQT as of Q2 2021.

  • Bank of Montreal reported no remaining Arcutis Biotherapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 677 Arcutis Biotherapeutics shares in Q2 2021, an estimated $19K.
  • Bank of Montreal first reported a position in Arcutis Biotherapeutics in Q2 2020 and held it in 4 quarters.
  • Bank of Montreal's Arcutis Biotherapeutics position peaked at $89K in Q4 2020.
  • 102 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.